Search for: "KING PHARMACEUTICALS, INC." Results 181 - 200 of 212
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2019, 6:00 am by Guest Blogger
For the symposium on Andrew Coan, Rationing the Constitution: How Judicial Capacity Shapes Supreme Court Decision-Making (Harvard University Press 2019).Frederick SchauerAndrew Coan’s important book[i]on the limits of the Supreme Court’s decision-making capacity is built on three foundational points, all of which are correct. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
17 May 2024, 1:07 pm by John Ross
On the other, it encourages generic pharmaceutical manufacturers to challenge name-brand patents while antitrust law prohibits anticompetitive deals. [read post]
9 May 2007, 1:28 am
ALM Privacy Policy / Contact Us © 2007 ALM Properties, Inc. [read post]
24 Dec 2021, 12:14 pm by Eugene Volokh
The father argues that he does not consent to the children receiving the vaccine because, he alleges, pharmaceutical producers received waivers against future litigation for unknown long-term effects. [read post]
26 Jan 2010, 7:06 am
Frank Brown ** Dean, INSEAD, France Panellists Kris Gopalakrishnan ** Chief Executive Officer and Managing Director, Infosys Technologies, India Jeffrey Joerres ** Chairman and Chief Executive Officer, Manpower Inc., USA Wallace King ** Chief Executive Officer, Leighton Holdings, Australia Fred van Leeuwen ** General Secretary, Education International, Belgium Lubna S. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]
3 Aug 2016, 2:19 pm by Michael Grossman
For instances, Super Samurai-X and Ginseng Power-X (as well as Tiger-X and Ninja-X) are distributed by SOS Telecom, Inc. out of Bayside, NY. [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
15 Dec 2014, 7:25 am
After the news of two of Europe's leading judges lending their support to the EPO's Enlarged Board of Appeal (who have asked the EPO's Administrative Council to curb the interference by the President in their work), further support arrives from additional national IP judges, all of whom also serve as external members of the Enlarged Board of Appeal, explains Merpel* BREAKING NEWS: EPO Communique -- Boards of Appeal "independent in principle"; "precautionary"… [read post]
16 Aug 2009, 11:23 am
The best example of the downside of optionality was the sale of United Rentals Inc. where the buyer, Cerberus, unabashedly chose to pay the break fee rather than close, despite the absence of any material problem in the URI business. [read post]
4 Jun 2012, 7:53 pm by Matthew Bush
Certiorari stage documents:Opinion below (5th Cir.)Petition for certiorariBrief in opposition (forthcoming)Reply of petitioners Amgen Inc. v. [read post]
23 Jan 2017, 1:25 am by INFORRM
The inauguration of President Donald J Trump on 20 January 2017 was the biggest media story in the world this week. [read post]